Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells for Drug Discovery & Toxicity Screening 2017

Robert Halliwell's Biography



Robert Halliwell, Professor of Neuroscience, University of The Pacific

Robert F. Halliwell completed postgraduate training in neurological science at University College London, in pharmacology at Ninewells Hospital & Medical School, University of Dundee and a Post-Doctoral Fellowship in Neuroscience at the University of California, Irvine. I previously held a lectureship in Neuroscience at the University of Durham, England and I am currently Professor in Neuroscience in the School of Pharmacy, University of the Pacific. I contribute to Schools of Neuroscience in Africa for IBRO; I am a member of the Medical Ethics Committee at St Joseph’s Medical Center, Stockton, CA, and an Advisor on Mental Health for the Wellness Center of San Joaquin County. My laboratory is addressing the properties and value of neurons derived from a variety of human stem cells for studies in neuropharmacology and neurotoxicology; I have also published work in the history of medicine.

Robert Halliwell Image

Electrophysiological Properties of Neurons Derived from Human Stem Cells In Vitro

Tuesday, 11 July 2017 at 08:00

Add to Calendar ▼2017-07-11 08:00:002017-07-11 09:00:00Europe/LondonElectrophysiological Properties of Neurons Derived from Human Stem Cells In VitroStem Cells for Drug Discovery and Toxicity Screening 2017 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

Neurons derived from human stem cells promise great advantages for drug discovery and safety testing, especially in the development of agents for neurological and psychiatric disorders. This presentation will describe recent data showing that human stem cells from a variety of sources can develop the morphological features of neurons and glia, display immunocytochemical markers and express a complex array of functional voltage- and ligand-gated ion channels; I will also consider the advantages and challenges of using different types of human stem cells to derive such neurons. Finally, data will be presented showing the sensitivity of human stem cells and their neural phenotypes to a range of clinically important psychotropic agents.


Add to Calendar ▼2017-07-10 00:00:002017-07-11 00:00:00Europe/LondonStem Cells for Drug Discovery and Toxicity Screening 2017Stem Cells for Drug Discovery and Toxicity Screening 2017 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com